世界と思いやりをシェア
医薬品・ヘルスケア産業のためのロジスティクスでアクセス、パフォーマンス、アカウンタビリティを向上。
Reducing GHG emissions in global logistics with Novo Nordisk
Discover how Novo Nordisk, together with Maersk, is transforming supply chains to lower greenhouse gas (GHG) emissions. Watch the video to learn about our efforts and ongoing journey towards decarbonisation in logistics.
Why temperature control and intervention is a life-saver for pharmaceutical cargo
Temperature control and timely intervention are critical to ensure the integrity of pharmaceutical cargo. Even slight deviations can compromise the quality of life-saving medicines, disrupt their movement, and set companies back. For a deep-dive into the strategies and technologies that safeguard these vital shipments, read an insightful article by our pharma specialist Sebastian Steinmueller.
AI and Pharma: the next best duo
Considering how artificial intelligence is already revolutionising all industries, how can AI change the pharmaceutical industry and its supply chains? What are the benefits and challenges? Explore the 7 ways artificial intelligence can boost the pharmaceutical industry in this research piece.
The importance of visibility for pharma supply chains
Time and quality control are key for pharma supply chains given the particularity of their cargo, but what role does visibility play? What exactly does visibility mean for pharma supply chains? In this research piece, see how better data can help visibility and what the future holds.
The ever-evolving cold chain needs of the pharma industry
Healthcare expenditure in the European Union is projected to surge to a staggering 350% by 2050. This seismic shift is reshaping the pharmaceutical landscape, propelling global cold chain investments to an anticipated 21.3 billion USD. But how are companies adapting? Join us as we uncover the transformative impact of market innovations on pharmaceutical logistics, guided by insights from Gaëtan Van Exem, Global Vertical Head of Pharma and Healthcare.
How a global pharma company reduced their GHG emissions
By choosing Maersk ECO Delivery Ocean, this pharma company was able to get closer to their decarbonisation goals while still delivering essential care all around the world.
Transforming pharma supply chains for the future
Read our latest article by Gaetan Van Exem, Global Vertical Head, Pharma and Healthcare Cold Chain Vertical which explains the vital role of trusted partnerships and truly integrated logistics in building reliable and resilient pharma cold chain solutions.
The great Indian pharma story
India is a global pharmaceutical powerhouse, on course to being a $450 billion industry by 2047. The country contributes to over 20% of the world's drug supply chain and manufactures over 60% of the global demand for vaccines. What makes the pharma industry tick in India? How are the latest innovations in technology changing the face of how the sector is run and the medicines transported? What supply chain challenges does it encounter?
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.
管理、接続、効率化
世界の主要な医薬品・ヘルスケア企業はマースクを活用して製品を安全に世界各地へ届けています。 深い専門知識、GDPコンプライアンス、エンドツーエンドのコールドチェーンソリューション、最新式コンテナを備え、長年にわたりサステイナビリティに取り組んできたマースクは医薬品ロジスティクスの最適なパートナーです。 マースクの医薬品サプライチェーンをインフォグラフィックで紹介します。
医薬品・ヘルスケアのサプライチェーンを新たな形でつなぐ
20年後、世界のサプライチェーンの進化を振り返った時、私たちはコロナ前とコロナ後という大きく異なる2つの時代を見るでしょう。 過去にもさまざまなウイルスの発生はありましたが、国際貿易がGDPの50％を占める現代の国際社会では未曾有の規模となりました。 これほどまでに多くのモノが多くの国を超え、多くの関係者を経て運ばれるサプライチェーンはこれまで存在しませんでした。 学術者やリスク管理者による理論上の演習や災害計画を除いて、サプライチェーンがこれほどまでの苦難にさらされたことはありませんでした。
医薬品やヘルスケアの分野では、プロフェッショナルたちが反応的対応の必要性と、より信頼性、透明性、インテリジェンスの優れたサプライチェーンの構築を両立させようとしています。 変化を実現するためには、製造から荷渡し、通関、保管、エンドカスタマーに至るまでのサプライチェーン全体を評価する必要があります。
このe-ブックでは、最新のイノベーションや展開を紹介し、医薬品・ヘルスケアロジスティクス全体の未来像を評価します。 その中で、マースクがプロセス、テクノロジー、協働における進化をつうじてエンドツーエンドのイノベーションを推し進めている主要な領域をいくつかご紹介します。
Re-evaluating the modal mix for pharmaceutical supply chains
Transporting the most fragile, high-value, regulated cargo in the world is complex. Even more so when you need to roll out billions of doses of a vaccine across continents to every person on the planet. Add to that the pressures of running a supply chain focused on reducing greenhouse gas (GHG) emissions, and pharma companies could find themselves in a dilemma. Unless they add a healthy dose of shipping to their modal mix. It’s reliable, makes essential products accessible to patients around the globe, and emits less GHG emissions than most other modes of transportation, such as air transportation.
